S. Gail Eckhardt
Director/Board Member bei EXELIXIS, INC.
Profil
S.
Gail Eckhardt is currently the Director at Exelixis, Inc., the Director at the Association of American Cancer Institutes, an Independent Director at Syros Pharmaceuticals, Inc., the Director at OncoTEX Inc., and a Member of the National Academies Cancer Policy Forum.
Previously, she served as the Director at the Cancer Therapy & Research Center Endowment, an Independent Director at NuGenerex Immuno-Oncology, Inc., the Director-Livestrong Cancer at The University of Texas at Austin, the Associate Director at Baylor College of Medicine, the Director at the American Society of Clinical Oncology, Inc., the Associate Director at Clinical Research Advantage, Inc., the Associate Director-Translational Research at The University of Colorado School of Medicine, the Associate Director at the University of Colorado Cancer Center, and a Professor at the University of Colorado Health Sciences Center.
She also worked as a Scientific Advisor at 5AM Venture Management LLC and served as the Head-Medical Oncology at The University of Colorado School of Medicine.
Additionally, she was the Chair-Oncology Department & Professor at Dell Medical School.
Dr. Eckhardt received her undergraduate degree from Stephen F.
Austin State University and her doctorate from the University of Texas Medical Branch.
Aktive Positionen von S. Gail Eckhardt
| Unternehmen | Position | Beginn |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Director/Board Member | 08.09.2020 |
| EXELIXIS, INC. | Director/Board Member | 05.01.2024 |
| OncoTEX Inc. | Director/Board Member | 01.01.2022 |
Association of American Cancer Institutes
 Association of American Cancer Institutes Miscellaneous Commercial ServicesCommercial Services Association of American Cancer Institutes operates as a membership association of academic and freestanding cancer research centers in the United States. It comprises 98 cancer research centers. The company is headquartered in Pittsburgh, PA. | Director/Board Member | 20.10.2019 |
Ehemalige bekannte Positionen von S. Gail Eckhardt
| Unternehmen | Position | Ende |
|---|---|---|
| Dell Medical School | Corporate Officer/Principal | 01.01.2023 |
| NUGENEREX IMMUNO-ONCOLOGY, INC. | Director/Board Member | 01.05.2021 |
| The University of Colorado School of Medicine | Corporate Officer/Principal | 01.01.2017 |
| The University of Colorado School of Medicine | Corporate Officer/Principal | 01.01.2014 |
| University of Colorado Health Sciences Center | Corporate Officer/Principal | - |
Ausbildung von S. Gail Eckhardt
| Stephen F. Austin State University | Undergraduate Degree |
| University of Texas Medical Branch | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
| Cancer Therapy & Research Center Endowment | Health Services |
NuGenerex Immuno-Oncology, Inc.
 NuGenerex Immuno-Oncology, Inc. BiotechnologyHealth Technology NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL. | Health Technology |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
Clinical Research Advantage, Inc.
 Clinical Research Advantage, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Research Advantage, Inc. provides research services to the pharmaceutical companies and clinical research organizations. The company was founded in 1992 and is headquartered in Tempe, AZ. | Commercial Services |
Association of American Cancer Institutes
Association of American Cancer Institutes Miscellaneous Commercial ServicesCommercial Services Association of American Cancer Institutes operates as a membership association of academic and freestanding cancer research centers in the United States. It comprises 98 cancer research centers. The company is headquartered in Pittsburgh, PA. | Commercial Services |
| OncoTEX Inc. |
